This national nonprofit organization commissioned us to visually explain how they work with patients, advocates, physicians, and insurers to recommend fair pricing for new drugs and other therapies.
Founded in 2006 and non-profit incorporated in 2013, ICER has become the nation’s non-partisan, independent, go-to-resource for objective evidence about the value of health care in the U.S. ICER’s appraisals of more than 100 drugs for more than 50 medical conditions, in addition to multiple devices and diagnostics, have demonstrated that rigorous, transparent analysis and application of evidence to clinical effectiveness and cost can align the price of care with the benefit it brings to patients and families in the U.S. Our ultimate goal is to improve access and affordability of treatments while retaining the incentives necessary for future innovation: Fair Price, Fair Access, and Future Innovation.
